Related Experiment Video
Updated: Jul 28, 2025

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.8K
Time to first transfusion in lower-risk patients with myelodysplastic neoplasia (MDS) is another prognostic factor of
Hans Tilman Steinmetz1, J Toczek-Thiel1, J Lipke2
1Outpatient Clinics for Hematology and Oncology, Cologne, Germany.
Leukemia & Lymphoma
|May 31, 2023
Abstract
No abstract available in PubMed .

